|
|
||||||||

* Department of Animal and Poultry Sciences, and
Department of Dairy Science, Virginia Polytechnic Institute and State University, Blacksburg 24061
3 Corresponding author: hojiang{at}vt.edu
| ABSTRACT |
|---|
|
|
|---|
i/11. In total, these results demonstrate that the bovine genome encodes functional GPR41 and GPR43 genes and suggest that GPR41 and GPR43 may play a role in the regulatory effects of VFA in cattle.
Key Words: G protein-coupled receptors GPR41 and GPR43 volatile fatty acids cattle
| INTRODUCTION |
|---|
|
|
|---|
The VFA are major sources of energy for ruminant animals. It is estimated that 60 to 70% of the energy requirement of cattle and sheep is provided by rumen VFA (Siciliano-Jones and Murphy, 1989). In addition to providing energy, VFA also play a regulatory role in several important physiological processes in cattle and sheep. Intraruminal administration of VFA stimulates rumen epithelial development (Sakata and Tamate, 1978, 1979; Lane and Jesse, 1997), whereas limiting rumen production of VFA inhibits rumen epithelium growth (Warner et al., 1956; Harrison et al., 1960; Tamate et al., 1962). Intravenous and intraportal infusions of propionate and butyrate increase serum concentrations of insulin and glucagon in sheep and cattle (Horino et al., 1968; de Jong, 1982; DiCostanzo et al., 1999). Intraruminal and intravenous infusions of propionate also inhibit feed intake in cattle (Faverdin, 1999; Allen, 2000). The VFA can also stimulate blood flow and motility of the gastrointestinal tract (Bergman, 1990; Cherbut, 2003) and inhibit liver cholesterol synthesis (Bergman, 1990).
Little is known about the mechanisms underlying the regulatory effects of VFA in cattle and sheep. Recent studies employing a "reverse pharmacology" approach identified short-chain fatty acids, including acetate, propionate, and butyrate, as ligands for orphan human G protein-coupled receptor 41 (GPR41) and 43 (GPR43; Brown et al., 2003; Le Poul et al., 2003; Nilsson et al., 2003). For this reason, GPR41 and GPR43 are also called free fatty acid receptor 3 (FFAR3) and 2 (FFAR2), respectively. Subsequent studies showed that GPR41 mediated the stimulation of short-chain fatty acids on leptin production in adipocytes (Xiong et al., 2004) and the effect of gut microbiota on host energy balance and adiposity (Samuel et al., 2008), and GPR43 was shown to mediate the stimulatory effect of short-chain fatty acids on adipogenesis (Hong et al., 2005) and inhibition of lipolysis (Ge et al., 2008).
It is possible that proteins similar to human GPR41 and GPR43 mediate the effects of VFA on rumen development, insulin and glucagon secretion, gastrointestinal motility, and feed intake in cattle. As a step toward testing this possibility, we determined in this study whether the bovine genome contains genes similar to the human GPR41 and GPR43 genes, whether and where these genes are expressed in cattle, and whether the protein products of these genes can interact with acetate, propionate, and butyrate.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Reverse Transcription and PCR
Reverse transcription (RT)-PCR was used to amplify the protein-coding regions of bovine GPR41 and GPR43 mRNA and to detect the expression of these mRNA in bovine tissues. Ten micrograms of total RNA was pooled equally from 2 animals and digested with 10 U of DNase I (Promega, Madison, WI) at 37°C for 30 min followed by standard protease K digestion and phenol-chloroform extraction. One microgram of the DNase I–digested RNA was reverse-transcribed to cDNA in a total volume of 20 µL using ImProm-II reverse transcriptase and random primers (Promega) according to the manufacturers instructions.
To amplify the protein-coding regions of bovine GPR41 and GPR43 mRNA, 50 ng of bovine spleen cDNA was mixed with 10 µL of 2x PCR Master Mix (Promega) and 10 pmol of primers bGPR41F1 and bGPR41R1, and primers bGPR43F1 and bGPR43R1, respectively (Table 1) in a total volume of 20 µL. The conditions of these PCR were 35 cycles of 94°C for 30 s, 60°C for 1 min, and 72°C for 1 min. The primers were designed based on the human GPR41 and GPR43 mRNA sequences in GenBank (accession numbers NM_005304 and NM_005306). The PCR products were resolved by standard agarose gel electrophoresis, and the DNA bands at expected sizes were purified from the gel using a QIAquick Gel Extraction Kit (Qiagen), according to the manufacturers instructions. The amplified GPR41 and GPR43 cDNA products were sequenced from both ends using the same primers for PCR (Table 1). The sequencing was performed by the Virginia Bioinformatics Institute Core Laboratory Facility (Blacksburg, VA).
|
5' Rapid Amplification of cDNA Ends
The 5' rapid amplification of cDNA ends (5' RACE) was used to amplify the 5' end regions of bovine GPR41 and GPR43 mRNA. This procedure was performed as described previously (Wang et al., 2003). Briefly, first-strand cDNA was transcribed from 1 µg of spleen poly(A) RNA using bGPR41 mRNA-specific primer bGPR41R2 or bGPR43 mRNA-specific primer bGPR43R2 as the reverse primer (Table 1). A homopolymeric cytosine tail was added to the 3' terminus of the cDNA using dCTP and terminal deoxyribonucleotide transferase (New England Biolabs, Ipswich, MA). The dCTP-tailed cDNA was then used as template in PCR to amplify the 5' end sequence of bGPR41 or bGPR43 cDNA using primers AAP and bGPR41R5, or primers AAP and bGPR43R5, respectively (Table 1). The product of this PCR was diluted at 1:1,000, and 1 µL of the dilution was used as template in PCR to further amplify the 5' end sequence of bGPR41 or bGPR43 cDNA, using primers AUAP and bGPR41R6, or primers AUAP and bGPR43R6, respectively (Table 1). The product of this PCR was resolved by gel electrophoresis. The DNA bands were isolated and cloned into the pGEM-T Easy vector (Promega), according to the manufacturers instructions.
Plasmid Construction
A 214-bp bGPR41 cDNA fragment and a 323-bp bGPR43 cDNA fragment were amplified from bovine spleen total RNA by RT-PCR, using primers bGPR41F2 and bGPR41R2, and bGPR43F2 and bGPR43R2, respectively (Table 1). These PCR products were cloned into the pGEM-T Easy vector (Promega), and the resulting plasmid constructs were named pGEM-TE-bGPR41 and pGEM-TE-bGPR43, respectively. A 1,052-bp bGPR41 DNA and a 1,093-bp bGPR43 DNA, which corresponded to the predicted protein-coding regions of bGPR41 and bGPR43 mRNA, were amplified from bovine genomic DNA using primers bGPR41F1 and bGPR41R1, and primers bGPR43F1 and bGPR43R1, respectively (Table 1). Genomic DNA instead of cDNA was used as template in these PCR because the protein-coding regions of bGPR41 and bGPR43 genes were found to be within one exon. The products of these PCR were cloned into the pcDNA3.1 vector (Invitrogen, Carlsbad, CA), and the resulting constructs were named pcDNA3-bGPR41 and pcDNA3-bGPR43, respectively. The same GPR41 and GPR43 protein-coding DNA regions were also amplified by PCR using primers bGPR41F1 and bGPR41R4, and primers bGPR43F1 and bGPR43R4, respectively (Table 1). These PCR products were cloned into pcDNA3.1 to generate constructs pcDNA3-bGPR41-FLAG and pcDNA3-bGPR43-FLAG. In these 2 constructs, the bGPR41 and bGPR43 protein-coding regions were fused to a FLAG peptide (DYKDDDDK) tag at their C-termini. All plasmid constructs were validated by DNA sequencing.
In Vitro Transcription and Translation
In vitro transcription and translation were used to validate the ability of the constructs pcDNA3-bGPR41 and pcDNA3-bGPR43 to express bGPR41 and bGPR43 proteins. The analysis was performed using the TNT In Vitro Transcription/Translation System (Promega). Briefly, 1 µg of pcDNA3-bGPR41 or pcDNA3-bGPR43 plasmid was transcribed and translated in a total volume of 50 µL, composed of 2 µL of TNT reaction buffer, 1 µL of TNT T7 RNA polymerase, 20 µM of amino acid mixture, 1 µL of 35S-methionine (PerkinElmer Life and Analytical Sciences, Wellesley, MA), 1 µL of RNasin ribonuclease inhibitor, and 25 µL of TNT rabbit reticulocyte lysate, at 30°C for 90 min. The translation products were resolved by electrophoresis through a 15% SDS polyacrylamide gel. The gel was fixed, dried, and visualized by autoradiography.
Cell Culture, Transient Transfection, and Luciferase Assay
Chinese hamster ovary (CHO) cells (ATCC, Manassas, VA) were used to express the bovine GPR41 and GPR43 proteins and to determine whether these proteins were activated by acetate, propionate, and butyrate. These cells were chosen because they are easy to transfect, provide stable and accurate posttranslational modification, and contain components for typical GPR signaling but no endogenous GPR41 or GPR43 (Itoh et al., 2003; Le Poul et al., 2003; Doupnik et al., 2004). The CHO cells were cultured in minimum essential medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL streptomycin (Sigma, St. Louis, MO). The cells at approximately 50% confluency were transfected with pcDNA3-bGPR41, pcDNA3-bGPR43, or pcDNA3.1 (empty vector), and the cyclic AMP (cAMP)-response reporter plasmid pCRE-Luc (Clontech, Mountain View, CA), using FuGene 6 as transfection reagent (Roche, Indianapolis, IN). Transfection efficiency was controlled by cotransfection of pRL-SV40 (Promega). Twenty-four hours after the transfection, the medium was replaced with serum-free minimum essential medium, and the cells were cultured for another 8 h. The cells were subsequently treated with different concentrations of sodium acetate, sodium propionate, sodium butyrate, or PBS for 16 h before being lysed for luciferase assay. The luciferase assay was done using the dual luciferase reporter assay system (Promega), essentially according to the manufacturers instructions. Some CHO cells were also transfected with pcDNA3-bGPR41, pcDNA3-bGPR43, pcDNA3-bGPR41-FLAG, pcDNA3-bGPR43-FLAG, or pcDNA3.1. Forty-eight hours after transfection, total RNA or total cellular proteins were isolated from the cells to confirm expression of bGPR41 or bGPR43 mRNA or protein.
Ribonuclease Protection Assay
The ribonuclease protection assay (RPA) was used to confirm the expression of bGPR41 and bGPR43 mRNA in the transfected CHO cells. The 32P-labeled riboprobes for bGPR41 and bGPR43 mRNA were transcribed from the pGEM-TE-bGPR41 and pGEM-TE-bGPR43 plasmids, respectively, by in vitro transcription in the presence of [
-32P]CTP (PerkinElmer Life and Analytical Sciences), as described previously (Wang et al., 2003). A 32P-labeled riboprobe was also synthesized from a mouse GAPDH cDNA plasmid prepared in a previous study (Eleswarapu et al., 2008). This probe was included in the RPA as a control for RNA loading. The RPA was performed using a RPAII kit (Ambion Inc., Austin, TX), as described previously (Wang et al., 2003). Briefly, 1 x 105 dpm of bGPR41, bGPR43, and GAPDH riboprobes were hybridized with 20 µg of total RNA in 20 µL of hybridization buffer for about 16 h at 42°C, and then digested with ribonucleases A and T1 at 37°C for 30 min. The undigested RNA fragments were precipitated and resolved through a 6% polyacrylamide gel containing 7 M urea. Following electrophoresis, the gel was dried, exposed to a phosphor-screen, and scanned on a Molecular Imager FX System (Bio-Rad, Hercules, CA).
Western Blotting Analysis
Total cellular protein lysates from cells were prepared as described previously (Zhou et al., 2008). Thirty micrograms of cellular protein lysates were separated through a 12% SDS polyacrylamide gel and then transferred to a nitrocellulose membrane (Bio-Rad). After being incubated in 5% nonfat dried milk for 3 h, the membrane was incubated with 1:1,000 diluted anti-FLAG M2 monoclonal antibody (Sigma) at 4°C overnight. After being washed 3 times in Tris-buffered saline-Tween, the membrane was incubated with 1:5,000 diluted horseradish peroxidase-conjugated donkey anti-mouse IgG antibody (Santa Cruz Biotechnology, Santa Cruz, CA) for 1 h at room temperature. The membrane was subsequently incubated in SuperSignal West Pico Chemiluminescence Substrate (Pierce Biotechnology, Rockford, IL) for 5 min, and the chemiluminescent signals were visualized by exposure to x-ray films. The membrane was then stripped by incubation in Restore Western Blot Stripping Buffer (Pierce Biotechnology) for 30 min at room temperature. The stripped membrane was probed with 1:1,000 diluted rabbit anti-β-actin antibody (Cell Signaling), and 1:5,000 diluted horseradish peroxidase-conjugated donkey anti-rabbit IgG antibody (Santa Cruz Biotechnology) to detect β-actin.
Statistical Analysis
The luciferase data were analyzed using the GLM procedure (SAS Inst. Inc., Cary, NC). The model included the effects of plasmid construct (pcDNA3.1, pcDNA3-bGPR41, pcDNA3-bGPR43), concentration of acetate, propionate, or butyrate, and plasmid x concentration interaction. Multiple means were compared using the Tukey analysis. All data were expressed as means ± SEM (standard error of the mean). A difference was considered statistically significant at P < 0.05.
| RESULTS |
|---|
|
|
|---|
Sequences of the Protein-Coding and 5' Untranslated Regions of bGPR41 and bGPR43 mRNA
The protein-coding sequences of bGPR41 and bGPR43 mRNA were amplified from spleen total RNA by RT-PCR. Spleen was chosen because preliminary experiments indicated that this tissue had a relative high-level expression of GPR41 and GPR43 mRNA. The RT-PCR generated DNA products at expected sizes. Sequencing of the DNA products revealed that they were more than 80% identical to human GPR41 and GPR43 mRNA sequences. The 5' end sequences of bGPR41 and bGPR43 mRNA were amplified by 5' RACE from spleen poly(A) RNA. Cloning and sequencing of the 5' RACE products revealed a single bGPR43 mRNA 5' end sequence and 2 different bGPR41 mRNA 5' end sequences. Aligning these 5' end sequences and the protein-coding sequences determined earlier as well as the EST sequences (BI541693, AW632495, AW660795, BE755048, CK773115, AW478068, CK977505, AJ813869, AJ818136) against the bovine genome database revealed the organization and transcription start sites of the bGPR41 and bGPR43 genes (Figure 1). The bGPR41 gene is composed of 3 exons, exon 1A, 1B, and 2 (Figure 1A). Transcription of the bGPR41 gene in the spleen is initiated at both exon 1A and exon 1B, generating GPR41–1A mRNA composed of exon 1A and exon 2, and GPR41–1B mRNA composed of exon 1B and exon 2 (Figure 1A). The bGPR43 gene contains 2 exons (Figure 1B). Transcription of this gene in the spleen is initiated from a single start site and, hence, generates a single bGPR43 mRNA transcript (Figure 1B). The bGPR41–1A, bGPR41–1B, and bGPR43 mRNA sequences are deposited in GenBank under accession numbers FJ562213, FJ562214, and FJ562212, respectively.
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Before this study, the sequences of GPR41 and GPR43 mRNA and, hence, the organization of the GPR41 and GPR43 genes had not been carefully characterized in any species. Most of the GPR41 and GPR43 mRNA sequences in GenBank resulted from computational predictions. In this study, we cloned and sequenced the protein-coding and the 5' untranslated regions of the bovine GPR41 and GPR43 mRNA. Based on these sequences, the bovine GPR41 gene contains 3 exons and the bovine GPR43 gene 2 exons; transcription of the bovine GPR43 gene is initiated from a single nucleotide; transcription of the bovine GPR41 gene is initiated from 2 different leader exons, generating mRNA variants differing in the 5' untranslated region. The 5' end nucleotide sequence of bovine GPR41 and GPR43 mRNA and the deduced N-terminal amino acid sequences of bovine GPR41 and GPR43 proteins determined in this study are different from those predicted by computational analyses (XM_605910, XM_600712). This underscores the need to validate experimentally the results of computational analyses.
Based on the deduced AA sequences, both bovine GPR41 and GPR43 proteins are membrane proteins containing 7 putative transmembrane domains, characteristic of G protein-coupled receptors (Wettschureck and Offermanns, 2005). In response to ligand binding, G protein-coupled receptors typically mediate changes in intracellular levels of second messengers cAMP, cyclic guanosine monophosphate, inositol trisphosphate (IP3), diacylglycerol (DAG), and Ca2+, depending on the type of G protein coupled to the receptor (Wettschureck and Offermanns, 2005). In this study, we have shown that interactions between bovine GPR41 and GPR43 and VFA inhibit reporter gene expression from a cAMP-response promoter in cells. This result demonstrates a functional link between bovine GPR41 and GPR43 proteins and acetate, propionate, and butyrate, and suggests that bovine GPR41 and GPR43 might couple with G
i/11, because activation of G
i/11 normally leads to reduced cAMP production, and reduced cAMP would explain reduced reporter gene expression from the cAMP-responsive plasmid (Wettschureck and Offermanns, 2005). In response to VFA, human GPR41 and GPR43 couple with G
i/11 to reduce intracellular cAMP production (Le Poul et al., 2003). The functional similarity between bovine and human GPR41 and GPR43 is not surprising because they share more than 75% identity in AA sequence. This study has also shown that in CHO cells without GPR41 or GPR43 overexpression, acetate, propionate, and butyrate stimulate cAMP signaling. The mechanism underlying this stimulatory effect of VFA on cAMP signaling is not clear, but apparently is not related to GPR41 or GPR43 because the CHO cells do not express endogenous GPR41 and GPR43 (Le Poul et al., 2003). In addition to activating GPR41 and GPR43, VFA (in particular, butyrate) are also known to function as histone deacetylase inhibitors and to affect gene expression through sequence-specific transcription factors and regulatory DNA sequences (Davie, 2003). Whether acetate, propionate, and butyrate stimulate cAMP-mediated gene expression by inhibiting histone deacetylase or by activating sequence-specific transcription factors remains to be determined.
This study has shown that GPR41 and GPR43 mRNA are widely expressed in cattle. This mirrors both human and rodent GPR41 and GPR43 mRNA results (Brown et al., 2003; Le Poul et al., 2003; Hong et al., 2005). Among the bovine tissues that express GPR41 and GPR43 mRNA are pancreas and rumen. Expression of GPR41 and GPR43 mRNA in these tissues supports the possibility that GPR41 and GPR43 might mediate the well-established effects of VFA on rumen development and insulin and glucagon secretion in cattle (Warner et al., 1956; Harrison et al., 1960; Tamate et al., 1962; Horino et al., 1968; Sakata and Tamate, 1978, 1979; Lane and Jesse, 1997). Adipose tissue is the only bovine tissue examined that does not express GPR41 or GPR43 mRNA. Absence of GPR41 and GPR43 expression in adipose tissue seems to be unique for cattle because these mRNA are expressed in human and rodent adipose tissue, where GPR41 and GPR43 have been further shown to mediate stimulation of VFA on leptin production and adipogenesis (Hong et al., 2005; Xiong et al., 2004) and inhibition of VFA on lipolysis (Ge et al., 2008). However, lack of GPR41 and GPR43 expression in bovine adipose tissue may explain why infusion of propionate does not change serum leptin concentration but does increase serum insulin concentration in cattle (Bradford et al., 2005).
In summary, this study has shown that the bovine genome encodes GPR41 and GPR43 genes, that the protein products of these genes can interact with acetate, propionate, and butyrate to inhibit cAMP signaling in vitro, and that these genes are expressed in various bovine tissues, including rumen and pancreas. These results demonstrate a novel functional link between GPR41 and GPR43 and VFA, suggesting that GPR41 and GPR43 might mediate the regulatory effects of VFA in cattle such as those on rumen development and insulin and glucagon secretion. In this study, we also determined the organization and transcription start sites of the bovine GPR41 and GPR43 genes. This information should be useful for studying how GPR41 and GPR43 genes are regulated in bovine tissues and has implications for the organization of the GPR41 and GPR43 genes in other species.
| FOOTNOTES |
|---|
|
|
|---|
2 Current address: Department of Life Science and Technology, Changshu Institute of Technology, Changshu, Jiangsu, China. ![]()
Received for publication January 15, 2009. Accepted for publication February 14, 2009.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. K. Mamedova, K. Robbins, B. J. Johnson, and B. J. Bradford Tissue expression of angiopoietin-like protein 4 in cattle J Anim Sci, January 1, 2010; 88(1): 124 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Allen, B. J. Bradford, and M. Oba BOARD-INVITED REVIEW: The hepatic oxidation theory of the control of feed intake and its application to ruminants J Anim Sci, October 1, 2009; 87(10): 3317 - 3334. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |